Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 149Fluorouracil 136Gemcitabine 117Bevacizumab 115Leucovorin 106Specimen Handling 105Capecitabine 95pembrolizumab 89Magnetic Resonance Spectroscopy 83Cisplatin 79Nivolumab 77Irinotecan 71durvalumab 63Cetuximab 62Paclitaxel 60Biopsy 60130-nm albumin-bound paclitaxel 60atezolizumab 44Radiotherapy 44Taxes 36Carboplatin 36Albumin-Bound Paclitaxel 36Folfox protocol 35Drug Therapy 31Cyclophosphamide 30lenvatinib 29dehydroftorafur 28tislelizumab 27sintilimab 27Radiation 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
DEAE-Dextran × Gastrointestinal × 90 days × Clear all
NCT07607119 2026-05-28

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Samsung Medical Center

Phase NA Recruiting
53 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

West China Hospital

Phase 1/2 Recruiting
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07463248 2026-03-11

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

West China Hospital

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡